Martin Hirsch
Overview
Explore the profile of Martin Hirsch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
842
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kalousios S, Hesser J, Dumpelmann M, Baumgartner C, Hamer H, Hirsch M, et al.
BMJ Open
. 2025 Feb;
15(2):e089903.
PMID: 39956604
Introduction: A novel focal cortex stimulation (FCS) device has recently received approval in Europe for patients with focal drug-resistant epilepsy (DRE). After 6 months of stimulation, 17 of 32 patients...
2.
3.
Martinez-Lizana E, Brandt A, Novitskaya Y, Hirsch M, Schulze-Bonhage A
Seizure
. 2025 Jan;
125:94-98.
PMID: 39817974
Purpose: To evaluate the efficacy of cenobamate (CNB) in adults with focal epilepsy based on the number of previous lifetime antiseizure medications (ASMs). Methods: Twenty patients receiving add-on treatment with...
4.
Novitskaya Y, Schulze-Bonhage A, Schutz E, Hirsch M
CNS Drugs
. 2024 Dec;
39(1):95-106.
PMID: 39638959
Background And Objective: Cenobamate is a novel anti-seizure medication (ASM) with unusually high responder rates even in patients with refractory epilepsy. Due to its enzyme-inducing properties, cenobamate could negatively affect...
5.
Schulze-Bonhage A, Steinhoff B, Garces M, Hirsch M, Villanueva V
Epilepsia Open
. 2024 Oct;
9(6):2537-2545.
PMID: 39388362
Objective: To assess antiseizure effects of cenobamate, a new antiseizure medication with at least two mechanisms of action, in the rare, highly pharmacoresistant and progressive epilepsy syndrome related to Rasmussen's...
6.
Griewing S, Lechner F, Gremke N, Lukac S, Janni W, Wallwiener M, et al.
J Cancer Res Clin Oncol
. 2024 Oct;
150(10):451.
PMID: 39382778
Purpose: Large language models (LLM) show potential for decision support in breast cancer care. Their use in clinical care is currently prohibited by lack of control over sources used for...
7.
Lewin J, Vashisht A, Hirsch M, Al-Wattar B, Saridogan E
BJOG
. 2024 Jul;
131(13):1793-1804.
PMID: 39010306
Objective: To compare the effectiveness of endometriosis excision alone to excision plus hysterectomy, with and without bilateral oophorectomy, for endometriosis-related symptoms. Design: Multicentre prospective cohort. Setting: Eighty-six specialist endometriosis centres....
8.
Zabler N, Swinnen L, Biondi A, Novitskaya Y, Schutz E, Epitashvili N, et al.
Sci Rep
. 2024 Jul;
14(1):15823.
PMID: 38982283
People with epilepsy frequently under- or inaccurately report their seizures, which poses a challenge for evaluating their treatment. The introduction of epilepsy health apps provides a novel approach that could...
9.
Bean E, Knez J, Thanatsis N, De Braud L, Taki F, Hirsch M, et al.
Fertil Steril
. 2024 Jun;
122(4):696-705.
PMID: 38838806
Objective: To determine whether obstetric outcomes differ between women with endometriosis and those without, where all women undergo first-trimester screening for endometriosis. Design: A prospective observational cohort study. Setting: The...
10.
Gandhi R, Hirsch M
N Engl J Med
. 2024 Apr;
390(13):1234-1236.
PMID: 38598581
No abstract available.